Martin Levinsohn
Delägare, AdvokatProfil
Jag arbetar med immaterialrätt och konkurrensrätt, ofta för klienter inom Life Sciences-branschen.
Jag har stor erfarenhet av att företräda klienter i tvister som rör patent och varumärken inför domstol, skiljenämnd och myndighet. I mitt dagliga arbete hjälper jag även företag med frågor som rör licenser, forsknings- och utvecklingssamarbeten, offentliga upphandlingar samt konkurrensrättsliga och regulatoriska frågor. Jag är van vid att driva och koordinera komplexa projekt med internationell anknytning.
2002-,
Setterwalls
2000-2001,
McGill University
2002,
Lunds universitet, jur. kand.
27 Jan 2023
Patent på lekplatsgungor var ogiltigt19 Aug 2022
Höga krav för ex parte-förbud enligt patentlagen10 Feb 2020
Setterwalls företrädde framgångsrikt Sandoz i patenttvist vid Patent- och marknadsdomstolen31 Jan 2020
Setterwalls företrädde framgångsrikt Teva i patenttvist vid Patent- och marknadsöverdomstolen13 Jun 2024
IAM 1000 Patent: Guld till Setterwalls20 May 2024
Update: Regeringen föreslår ny patentlag09 Mar 2023
Setterwalls företrädde framgångsrikt klient vid ogiltigförklaring av patent på sömnläkemedel10 Oct 2022
UPC öppnar sina dörrar den 1 april 202323 May 2022
The new European patent system23 May 2022
Single procedure for the granting of SPCs22 Apr 2022
Det nya europeiska patentsystemet22 Sep 2021
ICLG: Patent Law and Regulations 2022. Setterwalls experter förklarar svensk patenträtt i senaste upplagan.01 Mar 2021
EU har bötfällt spelplattformen Steam och fem spelutgivare 7,8 miljoner euro för geoblockering04 Jan 2021
UP/UPC Update: Nya klagomål i tyska författningsdomstolen mot Tysklands ratificering av UPCA24 Sep 2020
Setterwalls experter förklarar juridiken kring svenska patenttvister i årets upplaga av ICLG: Patents 202118 Sep 2020
UP/UPC Update: UPC Preparatory Committee signalerar ett funktionellt UPC inom en snar framtid30 Mar 2020
UP/UPC Update: Tyskland signalerar fortsatt stöd för UPC och arbete mot ratificering av domstolsavtalet27 Mar 2020
Kliniska prövningar under en pandemi – COVID-19 och dess påverkan på kliniska prövningar07 Oct 2019
Alla verks likhet inför lagen15 May 2019
SPC Waiver antagen av EU:s ministerråd18 Apr 2019
SPC Waiver godkändes av Europaparlamentet23 Aug 2018
Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden17 May 2017
Kan överprissättning av läkemedel vara olaglig?27 Dec 2016
Ny konkurrensskadelag25 Nov 2016
Update – Offentlig upphandling, november 201619 Sep 2016
Ny konkurrensskadelag på väg19 May 2016
Femårig konkurrensklausul i samband med förvärv tillåten denna gång – men vad innebär detta i praktiken?13 Apr 2016
Utökade möjligheter till förverkande05 Feb 2016
HFD uttalar sig om onormalt låga anbud – strategi med negativa anbudspriser kan vara godtagbar25 Nov 2015
Life Sciences Report November 201516 Nov 2015
Prisförhandla rätt!12 Nov 2015
Volymrabatter – vad är tillåtet?28 Nov 2014
Life Sciences Report November 201408 Apr 2014
Förslag om licens- och extemporeläkemedelExterna publikationer
Maj, 2012
TLV:s beslut slår hårt mot diabetiker, Dagens Medicin
2002
Skadestånd som sanktion mot karteller, Konkurrrensverkets A4-serie, medförfattare
”Martin Levinsohn is the name to note.”
Legal 500
”Martin is very responsive and technically able.”
Chambers Europe
”Martin is very precise and available, and has excellent knowledge of local patent law practices.”
Chambers Europe
”Martin is very responsive and technically able.”
Chambers Europe
”Martin is very precise and available, and has excellent knowledge of local patent law practices.”
Chambers Europe
”Martin is very precise and available, and has excellent knowledge of local patent law practices.”
Chambers Global
”Martin Levinsohn is really strong in how he manages cases, smart and has a good commercial sense.”
Chambers Global
”Instils confidence in clients with his ability to understand complex technical aspects and convert that into winning legal arguments. ”
IAM Patent 1000
”Martin Levinsohn – the captain of the ship with a steady hand on the helm. Significant representation of generic pharma clients in life sciences patents disputes.”
Legal 500
”Unafraid to test the bounds of patent law. He is one of the most important Swedish practitioners in the generics and biosimilars space, and along with having a brilliant grasp of complex technical aspects, he can translate those into arguments that are both clear and concise.”
IAM Patent (Gold)
”I'm very happy with Martin's services and trust his advice. He is calm, focused and delivers a great value-for-money input. He is not afraid to give ad-vice on commercial matters. ”
Chambers Global
”One of Sweden’s brightest lawyers, Martin is super innovative and finds brilliant new ways to tackle complicated matters. He is brilliant at grasping the technical aspects of a case and, most importantly, he is not afraid to push the boundaries of patent law. ”
IAM Patent
”A pragmatic lawyer who gives comprehensive advice.”
Chambers Europe
”Extremely skilled litigator.”
IAM Patent 1000
”A fantastic and shrewd lawyer.”
Chambers Global
”A pragmatic lawyer who gives comprehensive advice.”
Chambers Global
”Quick replies, personable nature and great collaboration with expert witnesses.”
IAM Patent
”The work of “extremely skilled litigator” Levinsohn is "always very thorough. His advice considers the business goals of his clients and the industries in which they operate".”
IAM Patent
”Recommended without hesitation for pan-European tasks is Martin Levinsohn. Responsive and well prepared, his advice is practical and well balanced. In the courtroom, he delivers measured, deliberate arguments that get straight to the point.”
IAM Patent
”a calm and collected attorney, he convincingly presents his cases to the court.”
IAM Patent
”a good communicator with a sharp mind.”
Legal 500
”Dedicated and very sharp.”
Legal 500
”He is a very good communicator, and extremely knowledgeable about marketing issues.”
Chambers
”Peers and clients regard Martin Levinsohn as "an extremely skilled lawyer." He is known for his patent and trade mark expertise relating to the pharma industry.”
Chambers
”Intellectual Property – Martin Levinsohn is the ‘sharp, competent’ practice head.”
Legal 500
”Martin Levihnson has deep knowledge and understanding of the pharma sector in Sweden”
Legal 500
”Martin Levinsohn is really strong in how he manages cases, smart and has a good commercial sense.”
Chambers & Partners Europe
”Martin Levinsohn is a very good operator and well-known name in the IP/patents field.”
Legal 500
”Martin Levinsohn and Karolina Jivebäck Pap: in addition to their outstanding knowledge of the sector and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios.”
Legal 500